Treatment of Melasma with Pulsed-Dye Laser and 1,064-nm Q-Switched Nd:YAG Laser: A Split-Face Study
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Melasma is an acquired pigmentary disorder that is often therapeutically challenging. Recent evidence suggests that vascular abnormalities are involved in melasma pathogenesis. Pulsed-dye laser (PDL) is considered as standard therapy for vascular lesions. Objective: To assess the efficacy of PDL combined with low-fluence Q-switched Nd:YAG laser (QSNY) in the treatment of melasma. Methods: Seventeen melasma patients were enrolled in this study. All subjects were treated with a total of nine QSNY treatment sessions at one-week intervals. Three sessions of PDL were additionally performed immediately after QSNY treatment on the half of the face at baseline, week 4, and week 8. The melasma area and the severity index (MASI) score was calculated at the baseline, one week after the last treatment (week 9), as well as at the follow-up 8 weeks after the last treatment (week 16). Dermoscopic images at the baseline were classified as to whether the visibly widened capillaries were detected or not. Results: MASI scores on the PDL+QSNY and QSNY side decreased significantly during the study period. There was no significant difference in the MASI score change between both sides in all periods. However, seven patients who had visibly widened capillaries on dermoscopy showed significant difference in both sides in terms of changes in the MASI score during treatment. Conclusion: PDL combined with QSNY may be considered as a safe and effective treatment for melasma patients who show visibly widened capillaries on dermoscopy.
Abstract
Background: Melasma is an acquired pigmentary disorder that is often therapeutically challenging. Recent evidence suggests that vascular abnormalities are involved in melasma pathogenesis. Pulsed-dye laser (PDL) is considered as standard therapy for vascular lesions. Objective: To assess the efficacy of PDL combined with low-fluence Q-switched Nd:YAG laser (QSNY) in the treatment of melasma. Methods: Seventeen melasma patients were enrolled in this study. All subjects were treated with a total of nine QSNY treatment sessions at one-week intervals. Three sessions of PDL were additionally performed immediately after QSNY treatment on the half of the face at baseline, week 4, and week 8. The melasma area and the severity index (MASI) score was calculated at the baseline, one week after the last treatment (week 9), as well as at the follow-up 8 weeks after the last treatment (week 16). Dermoscopic images at the baseline were classified as to whether the visibly widened capillaries were detected or not. Results: MASI scores on the PDL+QSNY and QSNY side decreased significantly during the study period. There was no significant difference in the MASI score change between both sides in all periods. However, seven patients who had visibly widened capillaries on dermoscopy showed significant difference in both sides in terms of changes in the MASI score during treatment. Conclusion: PDL combined with QSNY may be considered as a safe and effective treatment for melasma patients who show visibly widened capillaries on dermoscopy.
참고문헌 (17)
- Grimes PE. Melasma, "Etiologic and therapeutic considerations", Arch Dermatol, 131, pp.1453~1457 (1995)[DOI]
- Cho SB, "Melasma treatment in Korean women using a 1064-nm Q-switched Nd:YAG laser with low pulse energy", Clin Exp Dermatol, 34, pp.e847~e850 (2009)[DOI]
- Wattanakrai P, "Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians", Dermatol Surg, 36, pp.76~87 (2010)[DOI]
- Chan NP, "A case series of facial depigmentation associated with low fluence Q-switched 1,064 nm Nd:YAG laser for skin rejuvenation and melasma", Lasers Surg Med, 42, pp.712~719 (2010)[DOI]
- Kim EH, "The vascular characteristics of melasma", J Dermatol Sci, 46, pp.111~116 (2007)[DOI]
- Kim EJ, "Modulation of vascular endothelial growth factor receptors in melanocytes", Exp Dermatol, 14, pp.625~633 (2005)[DOI]
- Geddes ER, "Long-pulsed dye laser of 595 nm in combination with pigment-specific modalities for a patient exhibiting increased vascularity within lesions of melasma", Dermatol Surg, 42, pp.556~559 (2016)[DOI]
- Lee HI, "Clinicopathologic efficacy of copper bromide plus", yellow laser (578 nm with 511 nm) for treatment of melasma in Asian patients, 2010, pp.36, 885~893
- Passeron T, "Long-lasting effect of vascular targeted therapy of melasma", J Am Acad Dermatol, 69, pp.e141~e142 (2013)[DOI]
- Passeron T, "Melasma treatment with pulsed-dye laser and triple combination cream: a prospective, randomized, single-blind, split-face study", Arch Dermatol, 147, pp.1106~1108 (2011)[DOI]
- Na JI, "Effect of tranexamic acid on melasma: a clinical trial with histological evaluation", J Eur Acad Dermatol Venereol, 27, pp.1035~1039 (2013)[DOI]
- Grimes PE, "The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups", Dermatol Surg, 25, pp.18~22 (1999)[DOI]
- Pathak MA, "Usefulness of retinoic acid in the treatment of melasma", J Am Acad Dermatol, 15, pp.894~899 (1986)[DOI]
- Mun JY, "A low fluence Q-switched Nd:YAG laser modifies the 3D structure of melanocyte and ultrastructure of melanosome by subcellularselective photothermolysis", J Electron Microsc (Tokyo), 60, pp.11~18 (2011)[DOI]
- Kim JH, "Subcellular selective photothermolysis of melanosomes in adult zebrafish skin following 1064-nm Q-switched Nd:YAG laser irradiation", J Invest Dermatol, 130, pp.2333~2335 (2010)[DOI]
- Se Young Na, "Intense Pulsed Light and Low-Fluence Q-Switched Nd:YAG Laser Treatment in Melasma Patients", Annals of Dermatology, 24(3), pp.267~273 (2012), 대한피부과학회[DOI]
- Park GH, "The degree of erythema in melasma lesion is associated with the severity of disease and the response to the low-fluence Q-switched 1064-nm Nd:YAG laser treatment", J Dermatolog Treat, 24, pp.297~299 (2013)[DOI]